On 2026-05-15, NervGen Pharma Corp. (NGEN) announced earnings per share of -0.09 for the fiscal quarter ending 2026-03-31, missing the average analyst estimate of -0.07.

The next expected annoucement date for quarterly earnings is 2026-08-21, with an average estimated earnings per share of -0.09 for the fiscal quarter ending 2026-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.